Mutations in BRCA1 and BRCA2 account for roughly 20–50% of hereditary breast-cancer cases and significantly increase women’s lifetime risk of both breast and ovarian carcinomas [2,5]. The gene discussed is BRCA1; the disease is ovarian carcinoma.